About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed ANAEMIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 6 individuals taking ALIZAPRIDE reported ANAEMIA to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and ANAEMIA. In doing so, we compare ALIZAPRIDE with other drugs that cause ANAEMIA, to help you evaluate whether or not ALIZAPRIDE causes ANAEMIA. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if ANAEMIA ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing ANAEMIA: 6
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where ANAEMIA is a reported side effect: 5.8824%

FDA reports of any drug causing ANAEMIA : 66542
Average percentage for all medicated patients where ANAEMIA is reported as a complication: 0.4170%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ANAEMIA:

ASPIRIN (7819 patients)
FOSAMAX (7678 patients)
HEPARIN SODIUM INJECTION (5267 patients)
ZOMETA (4897 patients)
VIOXX (4857 patients)
LASIX (4629 patients)
ACCUTANE (4471 patients)
PREDNISONE (3831 patients)
RIBAVIRIN (3775 patients)
COUMADIN (3076 patients)
REVLIMID (3065 patients)
AREDIA (2992 patients)
OMEPRAZOLE (2915 patients)
FUROSEMIDE (2905 patients)
LISINOPRIL (2814 patients)
DEXAMETHASONE (2750 patients)
LIPITOR (2743 patients)
FOLIC ACID (2710 patients)
PEGASYS (2688 patients)
NEXIUM (2653 patients)
PLAVIX (2530 patients)
PREDNISOLONE (2410 patients)
ALLOPURINOL (2380 patients)
ACETAMINOPHEN (2296 patients)
ARANESP (2235 patients)
PROTONIX (2197 patients)
METHOTREXATE (2130 patients)
DIGOXIN (2055 patients)
PRILOSEC (2040 patients)
SYNTHROID (2017 patients)
NORVASC (1938 patients)
HUMIRA (1935 patients)
AMBIEN (1888 patients)
NEURONTIN (1877 patients)
POTASSIUM CHLORIDE (1873 patients)
SIMVASTATIN (1872 patients)
DECADRON (1870 patients)
CARBOPLATIN (1862 patients)
WARFARIN SODIUM (1859 patients)
ATENOLOL (1842 patients)
REBETOL (1759 patients)
REMICADE (1688 patients)
LEVAQUIN (1687 patients)
HYDROCHLOROTHIAZIDE (1672 patients)
PEG-INTRON (1671 patients)
CELEBREX (1655 patients)
ZOLOFT (1655 patients)
ZOFRAN (1632 patients)
OXYCONTIN (1619 patients)
CISPLATIN (1597 patients)
LEVOTHYROXINE SODIUM (1596 patients)
ZOCOR (1571 patients)
CYCLOPHOSPHAMIDE (1499 patients)
XANAX (1494 patients)
TOPROL-XL (1481 patients)
VICODIN (1472 patients)
PREDNISONE TAB (1468 patients)
GLEEVEC (1466 patients)
ALBUTEROL (1460 patients)
PREVACID (1446 patients)
ATIVAN (1444 patients)
SEROQUEL (1439 patients)
COPEGUS (1409 patients)
PERCOCET (1406 patients)
VITAMIN D (1396 patients)
LORAZEPAM (1394 patients)
AMLODIPINE (1313 patients)
IBUPROFEN (1289 patients)
DIOVAN (1283 patients)
METFORMIN HCL (1263 patients)
MORPHINE (1223 patients)
FERROUS SULFATE TAB (1218 patients)
LEXAPRO (1208 patients)
INSULIN (1207 patients)
PROCRIT (1201 patients)
MULTI-VITAMINS (1200 patients)
LOVENOX (1199 patients)
VELCADE (1192 patients)
METOPROLOL TARTRATE (1179 patients)
OXYCODONE HCL (1157 patients)
PAXIL (1147 patients)
THALIDOMIDE (1137 patients)
FORTEO (1126 patients)
FLUOROURACIL (1124 patients)
GABAPENTIN (1089 patients)
LANTUS (1087 patients)
COMPAZINE (1050 patients)
DOXORUBICIN HCL (1043 patients)
VITAMIN B-12 (1030 patients)
AMOXICILLIN (1026 patients)
TAXOTERE (1021 patients)
EPOGEN (1020 patients)
CALCIUM (1004 patients)
COREG (999 patients)
IRON (995 patients)
LYRICA (974 patients)
PANTOPRAZOLE (969 patients)
BACTRIM (966 patients)
NITROGLYCERIN (961 patients)
FAMOTIDINE (955 patients)
LORTAB (952 patients)
DURAGESIC-100 (951 patients)
AVANDIA (943 patients)
CHEMOTHERAPEUTICS NOS (938 patients)
FLUCONAZOLE (938 patients)
LANSOPRAZOLE (928 patients)
PROZAC (927 patients)
COLACE (921 patients)
ZANTAC (920 patients)
AVONEX (920 patients)
ALDACTONE (920 patients)
FENTANYL (914 patients)
TAXOL (911 patients)
SPIRONOLACTONE (906 patients)
ALENDRONATE SODIUM (902 patients)
NEUPOGEN (901 patients)
REGLAN (893 patients)
VANCOMYCIN (882 patients)
CIPROFLOXACIN (866 patients)
TRAMADOL HCL (865 patients)
VINCRISTINE (860 patients)
ENALAPRIL MALEATE (853 patients)
CYCLOSPORINE (850 patients)
CYMBALTA (849 patients)
CALCIUM CARBONATE (841 patients)
PREMARIN (834 patients)
ACYCLOVIR (826 patients)
ENBREL (817 patients)
GEMZAR (815 patients)
METOPROLOL (802 patients)
RITUXIMAB (801 patients)
CLINDAMYCIN (799 patients)
CARVEDILOL (798 patients)
HEPARIN (796 patients)
PACLITAXEL (794 patients)
GLUCOPHAGE (792 patients)
AVASTIN (788 patients)
SOLIRIS (785 patients)
EXJADE (783 patients)
COZAAR (783 patients)
MORPHINE SULFATE (780 patients)
DIFLUCAN (778 patients)
ZYPREXA (772 patients)
LOPRESSOR (769 patients)
ADVAIR DISKUS 100/50 (769 patients)
RAMIPRIL (762 patients)
ALPRAZOLAM (760 patients)
ACTONEL (756 patients)
ZITHROMAX (753 patients)
BENADRYL (750 patients)
RANITIDINE (749 patients)
CELEXA (746 patients)
DILAUDID (745 patients)
ASCORBIC ACID (736 patients)
AUGMENTIN '125' (730 patients)
ACTOS (730 patients)
EFFEXOR (727 patients)
PEPCID (726 patients)
TAMOXIFEN CITRATE (724 patients)
DOXYCYCLINE (721 patients)
TRACLEER (721 patients)
MYCOPHENOLATE MOFETIL (720 patients)
FLEXERIL (720 patients)
XELODA (717 patients)
PEGINTERFERON ALFA-2A (711 patients)
CRESTOR (710 patients)
GEMCITABINE (709 patients)
RADIATION THERAPY (693 patients)
CLONAZEPAM (690 patients)
FEMARA (686 patients)
INCIVEK (678 patients)
TYLENOL (667 patients)
HERCEPTIN (666 patients)
GLIPIZIDE (662 patients)
BEVACIZUMAB (660 patients)
CYTOXAN (659 patients)
CIPRO (648 patients)
VOLTAREN (645 patients)
MULTI-VITAMIN (643 patients)
METOCLOPRAMIDE (642 patients)
CEPHALEXIN (637 patients)
SPIRIVA (635 patients)
KALETRA (634 patients)
TYLENOL (CAPLET) (631 patients)
ALLEGRA (630 patients)
ONDANSETRON (624 patients)
VITAMIN E (623 patients)
ZYRTEC (622 patients)
TYSABRI (622 patients)
ADRIAMYCIN PFS (622 patients)
NAPROXEN (621 patients)
NEXAVAR (621 patients)
FLOMAX (619 patients)
MAGNESIUM OXIDE (618 patients)
HEPARIN SODIUM (618 patients)
AFINITOR (617 patients)
NEULASTA (616 patients)
FLAGYL (615 patients)
GLYBURIDE (615 patients)
NYSTATIN (614 patients)
PROCRIT /00909301/ (608 patients)
MEGACE (605 patients)
PROMETHAZINE (601 patients)
MIRALAX (600 patients)
METHYLPREDNISOLONE (598 patients)
PROGRAF (586 patients)
MS CONTIN (581 patients)
HYDROCODONE (577 patients)
CLONIDINE (577 patients)
WELLBUTRIN (576 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ANAEMIA and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Reston Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use